% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Zebhauser:164202,
author = {Zebhauser, Paul Theo and Berthele, Achim and Franz,
Marie-Sophie and Goldhardt, Oliver and Diehl-Schmid, Janine
and Priller, Josef and Ortner, Marion and Grimmer, Timo},
title = {{A}ge-{D}ependency of {T}otal {T}au in the {C}erebrospinal
{F}luid {I}s {C}orrected by {A}myloid-β 1-40: {A}
{C}orrelational {S}tudy in {H}ealthy {A}dults.},
journal = {Journal of Alzheimer's disease},
volume = {83},
number = {1},
issn = {1387-2877},
address = {Amsterdam},
publisher = {IOS Press},
reportid = {DZNE-2022-00858},
pages = {155 - 162},
year = {2021},
abstract = {Tau proteins are established biomarkers of neuroaxonal
damage in a wide range of neurodegenerative conditions.
Although measurement of total-Tau in the cerebrospinal fluid
is widely used in research and clinical settings, the
relationship between age and total-Tau in the cerebrospinal
fluid is yet to be fully understood. While past studies
reported a correlation between age and total-Tau in the
cerebrospinal fluid of healthy adults, in clinical practice
the same cut-off value is used independently of patient's
age.To further explore the relationship between age and
total-Tau and to disentangle neurodegenerative from
drainage-dependent effects.We analyzed cerebrospinal fluid
samples of 76 carefully selected cognitively healthy adults
and included amyloid-β 1-40 as a potential marker of
drainage from the brain's interstitial system.We found a
significant correlation of total-Tau and age, which was no
longer present when correcting total-Tau for amyloid-β 1-40
concentrations. These findings were replicated under varied
inclusion criteria.Results call into question the
association of age and total-Tau in the cerebrospinal fluid.
Furthermore, they suggest diagnostic utility of amyloid-β
1-40 as a possible proxy for drainage-mechanisms into the
cerebrospinal fluid when interpreting biomarker
concentrations for neurodegenerative diseases.},
keywords = {Age Factors / Amyloid beta-Peptides: cerebrospinal fluid /
Biomarkers: cerebrospinal fluid / Female / Healthy
Volunteers: statistics $\&$ numerical data / Humans / Male /
Middle Aged / Models, Statistical / Peptide Fragments:
cerebrospinal fluid / tau Proteins: cerebrospinal fluid /
Alzheimer’s disease (Other) / amyloid-beta 1–40 (Other)
/ tau proteins (Other) / total-Tau (Other) / Amyloid
beta-Peptides (NLM Chemicals) / Biomarkers (NLM Chemicals) /
Peptide Fragments (NLM Chemicals) / amyloid beta-protein
(1-40) (NLM Chemicals) / tau Proteins (NLM Chemicals)},
cin = {AG Priller},
ddc = {610},
cid = {I:(DE-2719)5000007},
pnm = {353 - Clinical and Health Care Research (POF4-353)},
pid = {G:(DE-HGF)POF4-353},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:34250938},
doi = {10.3233/JAD-210286},
url = {https://pub.dzne.de/record/164202},
}